Abstract Body

The HIV prevention field finally has a highly effective biomedical intervention in oral PrEP. There has been a purposeful effort to expedite population level PrEP delivery, with different trajectories by different countries. During this session, we shall review the various strategies that guide PrEP Scale up. Walking through the journey and process taken by different countries in PrEP scale up. We will explore the characteristics of early adopters and factors that drive uptake and broad scale uptake by populations that most need it. We will discuss considerations raised by skeptics and their role in informing delivery process and the social and health benefits, beyond HIV prevention.